Two cases of psoriasis following growth hormone therapy

Young Soo Heo, Se Yeong Jeong, Jae Eun Choi, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye

Research output: Contribution to journalArticlepeer-review


Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH merapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.

Original languageEnglish
Pages (from-to)714-717
Number of pages4
JournalKorean Journal of Dermatology
Issue number6
Publication statusPublished - 2009 Jun
Externally publishedYes


  • Growth hormone
  • Insulin-like growth factor
  • Psoriasis

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Two cases of psoriasis following growth hormone therapy'. Together they form a unique fingerprint.

Cite this